Legal Marijuana Market Size, Share & Trends Analysis Report By Application (Medical, Adult Use), By Product Type (Flower, Oils and Tinctures), By Region, And Segment Forecasts, 2024 - 2030
Legal Marijuana Market Growth & Trends
The global legal marijuana market size is expected to reach USD 102.24 billion by 2030, according to a new study by Grand View Research, Inc. The market is expected to expand at a CAGR of 25.7% from 2024 to 2030. Increase in rate of legalization of marijuana for medicinal and adult-use/recreational marijuana, growing adoption of these products for the treatment of chronic ailments and rise in a number of new product launches are the primary factors responsible for the growth of the market. For instance, in March 2023, Irwin Naturals Inc., a herbal supplement formulator, introduced company's’ new CBD 25mg Softgels in Canada. It is available through the Starseed Medicinal Medical Group platform across the nation.
In April 2022, New Jersey legalized recreational and medical marijuana, and it is being sold at 13 facilities. This move has made New Jersey one of the 18 states in the United States where recreational marijuana is legal. The market is experiencing growth due to the widespread acceptance of cannabis and its high demand. Since its legalization, the use of marijuana in medical treatments has increased, leading to a decrease in the illegal trade of cannabis. According to a study conducted by New York University, the usage of cannabis among individuals aged 50-64 has doubled in the last decade and has now reached 9.0%.
Moreover, price of legal marijuana is lower than medical marijuana, and taxes would be levied on marijuana products after its legalization. Therefore, cultivators are focusing on cultivating marijuana in areas that are exempt from taxes. For instance, in New York, marijuana cultivators are focusing on tribal regions to get exempted from the taxes levied by the government. This is expected to lower the overall cost of cultivation of marijuana in the state, and cultivators can sell marijuana at lower prices. Lower prices of marijuana are further anticipated to boost the adoption of marijuana in the market.
Legal Marijuana Market Report Highlights
- By application, medical segment accounted for the largest revenue share of 79.1% in 2023 owing to the high demand among healthcare practitioners and patients for medicinal marijuana.
- By product type, oil and tinctures held the largest market share in 2023 owing to low price and ease of accessibility of flowers compared to other products.
- In 2023, North America dominated the overall market with a revenue share of 76.0% owing to its large consumer base, North America was among the first regions to legalize the use of medical and recreational cannabis.
- Chapter 1. Legal Marijuana Market: Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Application
- 1.2.2. Product Type
- 1.2.3. Regional scope
- 1.2.4. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR’s internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
- Chapter 2. Legal Marijuana Market: Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Application outlook
- 2.2.2. Product type outlook
- 2.2.3. Regional outlook
- 2.3. Competitive Insights
- Chapter 3. Legal Marijuana Market: Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Growing adoption of medical marijuana for treatment of chronic diseases
- 3.2.1.2. Growing legalization of medical marijuana in various countries
- 3.2.1.3. Elimination of black market through legalization of medical marijuana
- 3.2.1.4. Impending legalization of marijuana for recreational/adult use
- 3.2.2. Market restraint analysis
- 3.2.2.1. Lower market access of marijuana due to absence of legalization programs in several Asian and African countries
- 3.2.2.2. Legalization of medical marijuana only for selected indications
- 3.2.2.3. Supply shortage of medical marijuana in various countries
- 3.3. Legal Marijuana Market Analysis Tools
- 3.3.1. Industry Analysis – Porter’s
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- Chapter 4. Legal Marijuana Market: Application Estimates & Trend Analysis
- 4.1. Application Market Share, 2023 & 2030
- 4.2. Segment Dashboard
- 4.3. Global Legal Marijuana Market by Application Outlook
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.4.1. Medical
- 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.2. Cancer
- 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.3. Chronic Pain
- 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.4. Depression and Anxiety
- 4.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.5. Arthritis
- 4.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.6. Diabetes
- 4.4.1.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.7. Glaucoma
- 4.4.1.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.8. Migraines
- 4.4.1.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.9. Epilepsy
- 4.4.1.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.10. Multiple Sclerosis
- 4.4.1.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.11. AIDS
- 4.4.1.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.12. Amyotrophic Lateral Sclerosis
- 4.4.1.12.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.13. Alzheimer’s
- 4.4.1.13.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.14. Post-Traumatic Stress Disorder (PTSD)
- 4.4.1.14.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.15. Parkinson's
- 4.4.1.15.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.16. Tourette’s
- 4.4.1.16.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.17. Others
- 4.4.1.17.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2. Adult Use
- 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 5. Legal Marijuana Market: Product Type Estimates & Trend Analysis
- 5.1. Product Type Market Share, 2023 & 2030
- 5.2. Segment Dashboard
- 5.3. Global Legal Marijuana Market by Product Type Outlook
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.4.1. Flower
- 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2. Oil and tinctures
- 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 6. Legal Marijuana Market: Regional Estimates & Trend Analysis
- 6.1. Regional Market Share Analysis, 2023 & 2030
- 6.2. Regional Market Dashboard
- 6.3. Global Regional Market Snapshot
- 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 6.5. North America
- 6.5.1. U.S.
- 6.5.1.1. Key country dynamics
- 6.5.1.2. Regulatory framework/ reimbursement structure
- 6.5.1.3. Competitive scenario
- 6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.2. Canada
- 6.5.2.1. Key country dynamics
- 6.5.2.2. Regulatory framework/ reimbursement structure
- 6.5.2.3. Competitive scenario
- 6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6. Europe
- 6.6.1. UK
- 6.6.1.1. Key country dynamics
- 6.6.1.2. Regulatory framework/ reimbursement structure
- 6.6.1.3. Competitive scenario
- 6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.2. Germany
- 6.6.2.1. Key country dynamics
- 6.6.2.2. Regulatory framework/ reimbursement structure
- 6.6.2.3. Competitive scenario
- 6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.3. Netherlands
- 6.6.3.1. Key country dynamics
- 6.6.3.2. Regulatory framework/ reimbursement structure
- 6.6.3.3. Competitive scenario
- 6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.4. Italy
- 6.6.4.1. Key country dynamics
- 6.6.4.2. Regulatory framework/ reimbursement structure
- 6.6.4.3. Competitive scenario
- 6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.5. Spain
- 6.6.5.1. Key country dynamics
- 6.6.5.2. Regulatory framework/ reimbursement structure
- 6.6.5.3. Competitive scenario
- 6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.6. Croatia
- 6.6.6.1. Key country dynamics
- 6.6.6.2. Regulatory framework/ reimbursement structure
- 6.6.6.3. Competitive scenario
- 6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.7. Poland
- 6.6.7.1. Key country dynamics
- 6.6.7.2. Regulatory framework/ reimbursement structure
- 6.6.7.3. Competitive scenario
- 6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.8. Czech Republic
- 6.6.8.1. Key country dynamics
- 6.6.8.2. Regulatory framework/ reimbursement structure
- 6.6.8.3. Competitive scenario
- 6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.9. Switzerland
- 6.6.9.1. Key country dynamics
- 6.6.9.2. Regulatory framework/ reimbursement structure
- 6.6.9.3. Competitive scenario
- 6.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7. Asia Pacific
- 6.7.1. Japan
- 6.7.1.1. Key country dynamics
- 6.7.1.2. Regulatory framework/ reimbursement structure
- 6.7.1.3. Competitive scenario
- 6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.2. China
- 6.7.2.1. Key country dynamics
- 6.7.2.2. Regulatory framework/ reimbursement structure
- 6.7.2.3. Competitive scenario
- 6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.3. India
- 6.7.3.1. Key country dynamics
- 6.7.3.2. Regulatory framework/ reimbursement structure
- 6.7.3.3. Competitive scenario
- 6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.4. Australia
- 6.7.4.1. Key country dynamics
- 6.7.4.2. Regulatory framework/ reimbursement structure
- 6.7.4.3. Competitive scenario
- 6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.5. New Zealand
- 6.7.5.1. Key country dynamics
- 6.7.5.2. Regulatory framework/ reimbursement structure
- 6.7.5.3. Competitive scenario
- 6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.6. Thailand
- 6.7.6.1. Key country dynamics
- 6.7.6.2. Regulatory framework/ reimbursement structure
- 6.7.6.3. Competitive scenario
- 6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 6.8. Latin America
- 6.8.1. Brazil
- 6.8.1.1. Key country dynamics
- 6.8.1.2. Regulatory framework/ reimbursement structure
- 6.8.1.3. Competitive scenario
- 6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 6.8.2. Mexico
- 6.8.2.1. Key country dynamics
- 6.8.2.2. Regulatory framework/ reimbursement structure
- 6.8.2.3. Competitive scenario
- 6.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 6.8.3. Colombia
- 6.8.3.1. Key country dynamics
- 6.8.3.2. Regulatory framework/ reimbursement structure
- 6.8.3.3. Competitive scenario
- 6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 6.8.4. Colombia
- 6.8.4.1. Key country dynamics
- 6.8.4.2. Regulatory framework/ reimbursement structure
- 6.8.4.3. Competitive scenario
- 6.8.4.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 6.9. MEA
- 6.9.1. South Africa
- 6.9.1.1. Key country dynamics
- 6.9.1.2. Regulatory framework/ reimbursement structure
- 6.9.1.3. Competitive scenario
- 6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 6.9.2. Isarel
- 6.9.2.1. Key country dynamics
- 6.9.2.2. Regulatory framework/ reimbursement structure
- 6.9.2.3. Competitive scenario
- 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Company/Competition Categorization
- 7.3. Vendor Landscape
- 7.3.1. List of key distributors and channel partners
- 7.3.2. Key customers
- 7.3.3. Key company market share analysis, 2023
- 7.3.4. Canopy Growth Corporation
- 7.3.4.1. Company overview
- 7.3.4.2. Financial performance
- 7.3.4.3. Product benchmarking
- 7.3.4.4. Strategic initiatives
- 7.3.5. AURORA CANNABIS INC.
- 7.3.5.1. Company overview
- 7.3.5.2. Financial performance
- 7.3.5.3. Product benchmarking
- 7.3.5.4. Strategic initiatives
- 7.3.6. Tilray Brands Inc. (Aphria, Inc.)
- 7.3.6.1. Company overview
- 7.3.6.2. Financial performance
- 7.3.6.3. Product benchmarking
- 7.3.6.4. Strategic initiatives
- 7.3.7. ABcann Medicinals, Inc. (VIVO Cannabis Inc.)
- 7.3.7.1. Company overview
- 7.3.7.2. Financial performance
- 7.3.7.3. Product benchmarking
- 7.3.7.4. Strategic initiatives
- 7.3.8. The Cronos Group
- 7.3.8.1. Company overview
- 7.3.8.2. Financial performance
- 7.3.8.3. Product benchmarking
- 7.3.8.4. Strategic initiatives
- 7.3.9. MARICANN INC.
- 7.3.9.1. Company overview
- 7.3.9.2. Financial performance
- 7.3.9.3. Product benchmarking
- 7.3.9.4. Strategic initiatives
- 7.3.10. Organigram Holdings Inc.
- 7.3.10.1. Company overview
- 7.3.10.2. Financial performance
- 7.3.10.3. Product benchmarking
- 7.3.10.4. Strategic initiatives
- 7.3.11. Lexaria Bioscience
- 7.3.11.1. Company overview
- 7.3.11.2. Financial performance
- 7.3.11.3. Product benchmarking
- 7.3.11.4. Strategic initiatives
- 7.3.12. GW Pharmaceuticals (Jazz Pharmaceuticals, Inc.)
- 7.3.12.1. Company overview
- 7.3.12.2. Financial performance
- 7.3.12.3. Product benchmarking
- 7.3.12.4. Strategic initiatives
- 7.3.13. Tikun Olam
- 7.3.13.1. Company overview
- 7.3.13.2. Financial performance
- 7.3.13.3. Product benchmarking
- 7.3.13.4. Strategic initiatives
- 7.3.14. United Cannabis Corporation
- 7.3.14.1. Company overview
- 7.3.14.2. Financial performance
- 7.3.14.3. Product benchmarking
- 7.3.14.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook